View Moderna Report Covid19 Vaccine Latestage Data PNG. You can find more information in our data protection declaration. To date, moderna has demonstrated positive phase 1 data readouts for 6 prophylactic vaccines (h10n8, h7n9, rsv, chikungunya virus, hmpv/piv3 and cmv).

Keep Up to Date With COVID-19 Vaccine Development ...
Keep Up to Date With COVID-19 Vaccine Development ... from cdn.technologynetworks.com
Cnbc's meg tirrell reports on moderna's vaccine trial latest, which found a 94.5% efficacy rate. You can find more information in our data protection declaration. We can effectively end covid pandemic in 2021.

Moderna says it is a great day and they plan to apply for approval to use the vaccine in the next few weeks.

But there are still months to go before it will be widely available to the public. The vaccine was generally safe and was well tolerated, as determined on the. New vaccine data is important for market clarity: Moderna is the second company to report preliminary results from a large trial testing a vaccine.